The rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally altered the landscape of metabolic medicine in the United States.…
Read More

The rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally altered the landscape of metabolic medicine in the United States.…
Read More
Immuto Scientific, a company co-founded in 2018 by CEO Faraz A. Choudhury, Ph.D., and CTO Daniel Benjamin, Ph.D., both electrical…
Read More
In a landmark study that advances our understanding of reproductive biology, a multi-institutional research team led by Osaka University has…
Read More
The aging process exerts a profound and often debilitating toll on the hippocampus, the specialized region of the brain fundamentally…
Read More
Researchers at Johns Hopkins Medicine have unveiled a significant breakthrough in the quest to understand and eventually treat Alzheimer’s disease,…
Read More
In a significant advancement for neurodegenerative research, a scientific team at Oregon State University has successfully documented the real-time chemical…
Read More
Researchers at the Institute of Science Tokyo (Science Tokyo) have identified a critical protein, Family with Sequence Similarity 102 Member…
Read More
As the prevalence of glucagon-like peptide-1 (GLP-1) receptor agonists continues to reshape the landscape of metabolic health in the United…
Read More
Researchers from a consortium of international institutions have made a significant breakthrough in understanding the complex life cycle of the…
Read More
A groundbreaking development from Rice University has unveiled a simple yet powerful method to investigate pyroglutamate, a pervasive but historically…
Read More